Published in Lipids Health Dis on October 15, 2008
Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis (2012) 1.04
Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract (2010) 1.04
Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition (2011) 1.00
Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension. J Cardiovasc Pharmacol (2013) 0.99
Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing. Neurochem Int (2010) 0.97
Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats. Acta Pharmacol Sin (2009) 0.94
The implications of relationships between human diseases and metabolic subpathways. PLoS One (2011) 0.94
Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res (2012) 0.90
Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women. Eur J Nutr (2011) 0.89
Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Lipids Health Dis (2009) 0.86
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J Inflamm Res (2010) 0.86
Dietary meat fats and burden of cardiovascular disease risk factors, in the elderly: a report from the MEDIS study. Lipids Health Dis (2010) 0.86
Rice protein improves adiposity, body weight and reduces lipids level in rats through modification of triglyceride metabolism. Lipids Health Dis (2012) 0.84
A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians. Lipids Health Dis (2010) 0.83
Potential role of dietary lipids in the prophylaxis of some clinical conditions. Arch Med Sci (2015) 0.83
Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats. Exp Transl Stroke Med (2015) 0.83
Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro. PLoS One (2014) 0.82
Inhibitory potential of omega-3 fatty and fenugreek essential oil on key enzymes of carbohydrate-digestion and hypertension in diabetes rats. Lipids Health Dis (2011) 0.82
Topical Anti-Inflammatory Activity of Oil from Tropidurus hispidus (Spix, 1825). Evid Based Complement Alternat Med (2015) 0.81
Potential role of polyunsaturated fatty acids in diabetic retinopathy. Arch Med Sci (2014) 0.80
The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? Genes (Basel) (2016) 0.79
A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. World J Diabetes (2011) 0.78
Delta-6-desaturase gene polymorphism is associated with lipoprotein oxidation in vitro. Lipids Health Dis (2013) 0.78
Fish oil, but not soy bean or olive oil enriched infusion decreases histopathological severity of acute pancreatitis in rats without affecting eicosanoid synthesis. Inflammation (2011) 0.77
Dose-dependent effects of evening primrose oil in children and adolescents with atopic dermatitis. Ann Dermatol (2013) 0.77
Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cells. Br J Pharmacol (2011) 0.76
Nutraceutical therapies for atherosclerosis. Nat Rev Cardiol (2016) 0.76
Vagal nerve stimulation in prevention and management of coronary heart disease. World J Cardiol (2011) 0.76
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid. J Inflamm (Lond) (2015) 0.75
Dietary marine-derived long-chain monounsaturated fatty acids and cardiovascular disease risk: a mini review. Lipids Health Dis (2016) 0.75
Maternal exposure to fish oil primes offspring to harbor intestinal pathobionts associated with altered immune cell balance. Gut Microbes (2015) 0.75
Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats. Int J Physiol Pathophysiol Pharmacol (2014) 0.75
How have you used your SOAP today?: Considering the effects of food and environment on gene expression. Can Fam Physician (2010) 0.75
Lipoxin A4 and Neutrophil/Lymphocyte Ratio: A Possible Indicator in Achieved Systemic Risk Factors for Periodontitis. Med Sci Monit (2015) 0.75
Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions. Arch Med Sci (2016) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56
Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med (2007) 6.79
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet (2007) 6.57
Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol (2001) 5.87
The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med (1985) 4.79
N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med (2002) 4.33
Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med (1997) 4.27
Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology (1994) 4.27
Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation (2002) 4.12
Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A (1993) 3.93
Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci U S A (1995) 3.72
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60
Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation (2004) 3.44
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Two decades of progress in preventing vascular disease. Lancet (2002) 3.30
Rise in insulin resistance is associated with escalated telomere attrition. Circulation (2005) 3.27
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 3.26
Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. BMJ (2005) 3.00
Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med (1976) 2.91
Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics (2003) 2.86
Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med (2002) 2.83
Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol (2006) 2.75
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet (2003) 2.68
Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature (2007) 2.56
Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (2006) 2.43
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med (2007) 2.41
Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension (2004) 2.41
Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol (2006) 2.29
Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J (2006) 2.28
Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care (2006) 2.24
Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12
Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol (2007) 2.11
Resolvins and protectins in the termination program of acute inflammation. Trends Immunol (2007) 2.06
Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr (2006) 2.04
Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation (2006) 2.00
Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis (2004) 1.88
Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol (2003) 1.84
Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int (2006) 1.83
Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med (2004) 1.79
n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr (2003) 1.73
Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr (2004) 1.70
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med (2004) 1.69
Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest (1999) 1.64
Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern Med (2003) 1.64
Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A (1995) 1.61
Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet (1987) 1.59
Shortened telomere length in white blood cells of patients with IDDM. Diabetes (1998) 1.52
Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men. Lancet (1984) 1.50
Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med (2003) 1.48
Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci (2007) 1.47
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study. Eur Heart J (2004) 1.46
eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res (2001) 1.45
Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol (2006) 1.44
Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics (2001) 1.43
Maternal folic acid supplementation to dams on marginal protein level alters brain fatty acid levels of their adult offspring. Metabolism (2006) 1.43
Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A (1994) 1.43
A quantitative analysis of fish consumption and stroke risk. Am J Prev Med (2005) 1.39
Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol (2006) 1.35
Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol (2000) 1.33
Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res (2007) 1.33
Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res (2006) 1.31
An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med (2003) 1.30
Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res (2000) 1.29
Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand (2004) 1.23
Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot Essent Fatty Acids (2000) 1.19
Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol (Tokyo) (1982) 1.18
Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol (2006) 1.17
Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci U S A (2006) 1.16
Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol (1997) 1.16
Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth (2007) 1.15
Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics (2003) 1.11
Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol (2006) 1.10
Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res (2003) 1.10
Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology (2005) 1.09
Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr (1999) 1.07
Novel omega -- 3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther (2005) 1.07
Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (1997) 1.06
Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Eur J Pharmacol (1996) 1.06
A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids (2007) 1.06
Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol (2006) 1.04
Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why? Prostaglandins Leukot Essent Fatty Acids (2007) 1.04
Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants. J Health Popul Nutr (2006) 1.04
A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids (2007) 1.03
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest (1993) 1.03
Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr (2004) 1.01
Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis (2007) 1.11
Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis (2008) 0.93
Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives. Curr Pharm Biotechnol (2006) 0.90
A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians. Lipids Health Dis (2010) 0.83
Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus? Lipids Health Dis (2011) 0.81
Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? Lipids Health Dis (2008) 0.78
Effect of gamma-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot Essent Fatty Acids (2006) 0.77